"We are thrilled to introduce MOUNJARO, which represents the first new class of type 2 diabetes medication introduced in almost a decade and embodies our mission to bring innovative new therapies to the Australian diabetes community," said Tori Brown, the general manager of Eli Lilly Australia. …
Lilly goes for private launch of first-in-class diabetes therapy
August 24, 2023 Latest NewsBioPharma
Latest Video
New Stories
-
Applications now open for Moderna MRNA-focused research program
May 15, 2025 - - Latest News -
Portfolio change has real implications for stakeholders, with a revised approach required
May 15, 2025 - - Latest News -
Novo Nordisk announces departure of Cem Ozenc to lead new global team
May 15, 2025 - - Latest News -
The 'Dispatched' week in review podcast - 16 May
May 15, 2025 - - Podcast -
UK health secretary identifies weight loss therapies as one solution to broader issue
May 15, 2025 - - Latest News -
CSL Behring wins major international pharmaceutical engineering award
May 14, 2025 - - Latest News -
Lumos advances FebriDx sales with iMedical purchase order
May 14, 2025 - - Australian Biotech